This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A look at Addex Therapeutics' ADX71149/JNJ-40411813 in combination with Levetiracetam or Brivaracetam in patients with Epilepsy

Ticker(s): ADXN, JNJ

Who's the expert?

Institution: Montefiore Medical Center

  • Assistant Professor, The Saul R. Korey Department of Neurology (Pediatric Neurology) at Montefiore Medical Center.
  • Manages >50 patients with focal epilepsy. 
  • Research interest in pediatric neurology and epilepsy and familiar with the XEN1101 data.

Interview Goal
Discuss JNJ-40411813

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.